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Abstract  23 
The pathogenesis of infectious diseases depends on the interaction of host and pathogen but their 24 
simultaneous assessment is rare. In Plasmodium falciparum malaria, host and parasite processes can 25 
be assessed by dual RNA-sequencing of blood. Here we integrate dual transcriptome analyses with 26 
estimates of parasite load and detailed clinical information from 46 Gambian children to reveal 27 
mechanisms driving the systemic pathophysiology of severe malaria.  We report hundreds of human 28 
and parasite genes differentially expressed between severe and uncomplicated malaria, with distinct 29 
profiles associated with coma, hyperlactatemia and thrombocytopenia. High expression of 30 
neutrophil granule-related genes was consistently associated with all severe malaria phenotypes. 31 
We observed previously uncharacterized, severity-associated variation in expression of parasite 32 
genes which determine cytoadhesion and rigidity of infected erythrocytes and parasite growth rate. 33 
Up to 99% of human differential expression was driven by differences in parasite load, whilst 34 
parasite gene expression showed little association with parasite load. Co-expression analyses 35 
revealed interactions between species, with prominent co-regulation of translation genes in severe 36 
malaria hinting at a molecular arms race between host and parasite. In multivariate analyses 37 
increased expression of granulopoiesis and interferon-γ related genes, together with inadequate 38 
suppression of type-1 interferon signalling best explained severity. Our findings highlight the 39 
importance of considering both host and pathogen when interpreting the pathogenesis of infectious 40 
diseases. We implicate simultaneous contributions of host and parasite genes to human severe 41 
malaria pathogenesis, identifying potential new targets for adjunctive therapy.   42 
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Introduction 43 
Most studies of infectious disease pathogenesis focus on either host or pathogen, despite the fact 44 
that outcome is determined by their combined effects and interaction. Dual RNA-sequencing has 45 
developed as a method for transcriptomic assessment of such interactions (1, 2), although it has not 46 
been widely applied to study systemic infection in humans. Malaria is a good paradigm for this, 47 
because the pathogenic stage of the parasite is restricted to blood and within the blood many of the 48 
important interactions between parasites and host leukocytes occur (3). The blood is also the 49 
conduit for systemic responses to infection, and gene expression in blood will reflect the 50 
inflammatory and metabolic milieu to which leukocytes and pathogens are exposed.     51 
Plasmodium falciparum malaria is one of the most important infectious diseases affecting 52 
humankind (3). Most malaria deaths occur in children, in whom three major severe malaria (SM) 53 
syndromes are associated with increased risk of death: cerebral malaria (CM, manifesting as coma), 54 
hyperlactatemia / acidosis (HL, often manifesting as deep breathing), and severe anemia (3-6). These 55 
are usually accompanied by the typical laboratory finding of low platelet count (thrombocytopenia) 56 
(7). SM syndromes can occur in isolation or in overlapping combinations (4), and mortality is highest 57 
when CM and HL coexist (CH) (4). SM is most likely when there is a high parasite load (8-11) and 58 
numerous accompanying pathophysiological derangements have been described (4, 5, 12), broadly 59 
arising from inflammation, vascular endothelial dysfunction and parasite sequestration 60 
(accumulation of parasitized erythrocytes in small blood vessels, obstructing blood flow) (4, 13). 61 
These mechanisms interact with one another so defining their individual contributions to specific 62 
features of SM is challenging (13, 14). 63 
The host immune response is a major determinant of outcome in rodent models of SM (15, 16) and 64 
it has long been supposed that an excessive host response may also contribute to some forms of 65 
human SM (17, 18). A similar concept exists to explain severity in other infections such as bacterial 66 
sepsis,  (19-21), however direct evidence is often lacking and 67 
the confounding effect of pathogen load on the magnitude of the host response is rarely quantified. 68 
Ebola and Respiratory Syncytial Virus
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he relationship between pathogen 69 
to infection (22) but cannot be extended to investigate 70 
. To better understand the pathogenesis of severe infection an integrated 71 
view of host-pathogen interaction at a systemic scale and accounting for variation in pathogen load 72 
is required. 73 
The feasibility of host and parasite dual-RNA sequencing in malaria has been demonstrated in 74 
individuals with uncomplicated malaria (UM) (23). Here, we extend the application of dual-RNA 75 
sequencing to infectious disease pathogenesis by integrating analysis of gene expression with 76 
detailed clinical and laboratory data which characterise the systemic pathophysiology of SM. We 77 
refine the analysis further by accounting for three major confounders which may vary within and 78 
between severity groups: leukocyte proportions in blood, parasite developmental stage distribution, 79 
and variation in whole body pathogen load. We characterise human and parasite differential gene 80 
expression between SM and UM, the association of gene expression with specific pathophysiological 81 
features, the role of parasite load in determining the host response, and networks of interaction 82 
between host and parasite gene expression. These data provide a unique insight into host-pathogen 83 
interactions associated with severity of infection in humans and reveal novel perspectives on the 84 
likely pathogenic mechanisms of human SM. 85 
 86 
Results 87 
Host and parasite RNA-sequencing  88 
We performed dual-RNA sequencing on whole blood of 46 Gambian children with P. falciparum UM 89 
(n=21) and SM (n=25) (Table 1). These children were recruited from a region with relatively low 90 
malaria transmission and consistent with this (4) the SM group contained children with CM, HL and 91 
CH, but no cases of severe anemia. After exclusion of parasite var, rifin, stevor (14) and other highly 92 
polymorphic regions for which reference genome-based mapping is not possible (see Methods), we 93 
obtained medians of 26.6 million (26.6 million SM, 26.7 million UM, P=0.913) human and 9.61 94 
Controlled human infection models have provided insights into t
load and early immune responses 
associations with severity
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million (10.3 million SM, 5.03 million UM, P=0.346) parasite uniquely mapped reads from each 95 
subject (Fig 1A). We detected expression of 12253 human and 3880 parasite genes. Commensurate 96 
with the high parasitemias seen in these children (Table 1), parasite read depth was considerably 97 
greater than in a previous study of Indonesians with UM (23).  98 
 99 
Deconvolution and adjustment for cellular heterogeneity  100 
Systemic infection provokes changes in blood leukocyte subpopulations which can dominate 101 
changes in gene expression and confound their interpretation (24). A102 
ferences between clinical groups in the proportions of neutrophils (P=0.01) 103 
(P=0.05) 104 
counts . To overcome this we performed gene signature-based deconvolution (25) to 105 
estimate heterogeneity in the contribution of the major leukocyte subpopulations to the RNA in our 106 
samples (Fig 1B, Supplementary Fig 1). Parasite gene expression in vivo is also dominated by the 107 
mixture of parasite developmental stages at the time of sampling because there is phasic variation in 108 
gene expression (26) and increasing total RNA content during the intraerythrocytic developmental 109 
cycle (27). Therefore we sought to apply the same approach with reference gene signatures derived 110 
from highly synchronous parasite cultures (26, 28) to identify the contribution of parasites at 111 
different developmental stages (Fig 1C).  Since the method was developed and validated for distinct 112 
human cell types we confirmed the effectiveness of estimation of parasite developmental stage 113 
mixture by comparison with previously proposed stage-specific marker genes (29), and by 114 
assessment of performance in synthetic datasets of known composition (Supplementary Fig 2). We 115 
compared relative contributions of parasite developmental stages between SM and UM samples and 116 
observed a trend towards greater contributions from late stage asexual parasites and gametocytes 117 
in children with SM (Fig 1D), consistent with previous reports (30).  118 
  119 
mongst our study subjects 
there were significant dif
and lymphocytes in blood, although there were no significant differences in absolute cell 
(Table 1)
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 120 
Figure 1. Whole blood dual RNA-sequencing and deconvolution. (A) Uniquely mapped reads from 121 
human (red) and P. falciparum (blue) from subjects with severe (SM, n=25) and uncomplicated 122 
malaria (UM, n=21). (B,C) Heatmaps showing signature gene expression for different leukocyte (B) 123 
and parasite developmental stage (C) populations (rows) and their relative intensity in individual 124 
subjects with SM, including different SM phenotypes (CH, cerebral malaria plus hyperlactatemia; 125 
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CM, cerebral malaria; HL, hyperlactatemia), and UM (columns).  (D) Surrogate proportion variables 126 
for parasite developmental stages compared between SM and UM using the Mann-Whitney test 127 
(bold line, box and whiskers indicate median, interquartile range and 1.5-times interquartile range 128 
respectively). (E,F) Principal component plots showing the effect of deconvolution on the 129 
segregation of subjects with UM and SM, adjusting human (E) and parasite (F) gene expression for 130 
differences in proportions of leukocytes or parasite developmental stages respectively. Analyses of 131 
human gene expression (B,E): SM, n=25; UM, n=21.  Analyses of parasite gene expression (C,D, F): 132 
SM, n=23; UM, n=20.  133 
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In order to remove the confounding effect of heterogeneity in leukocyte and parasite mixtures we 134 
adjusted gene expression values for cell mixtures, essentially allowing us to compare gene 135 
expression as if all subjects had the same leukocyte and parasite population compositions.  136 
137 
138 
139 
140 
141 
 142 
Human differential gene expression in severe malaria 143 
144 
145 
Table 1). Amongst these some were highly significant and conspicuously higher expressed in SM 146 
relative to UM (high log-fold change), most notably MMP8 (matrix metallopeptidase 8), OLFM4 147 
(olfactomedin 4), DEFA3 (defensin A3), and ELANE (neutrophil elastase), all encoding neutrophil 148 
granule proteins (31). Due to the adjustment for cellular heterogeneity this likely reflects a true 149 
increase in transcription of these genes rather than a greater proportion of neutrophils in the blood. 150 
We performed Gene Ontology (GO) analyses to better understand the biological functions of the 151 
DEGs (Fig 2B) and identified enrichment of genes controlling co-translational protein targeting, cell 152 
motility and immune response functions (Supplementary Table 2). We used Ingenuity Pathway 153 
Analysis to predict upstream regulators of the differentially expressed genes, and colony stimulating 154 
factor 3 (CSF3, also known as granulocyte colony stimulating factor, GCSF), Fas cell surface death 155 
receptor, and Prostaglandin E receptor 2 signalling were the most significant (Supplementary Table 156 
3). We repeated similar analyses to identify and interpret DEGs between UM and different clinical 157 
phenotypes of SM (Supplementary Fig 3, Supplementary Tables 1&2), which revealed many 158 
consistent associations but also some notable differences. For example the number of DEGs was 159 
(DEGs, with false discovery rate (FDR)-adjusted P<0.05) between SM and UM (Fig 2A, Supplementary 
Considering all subjects together there were 770 human significantly differentially expressed genes 
Adjustment for heterogeneity in the mixture of leukocytes and parasite developmental stages 
improved segregation of SM and UM cases (Fig. 1E, F; multivariate ANOVA for human gene 
expression P=0.0013 and P = 0.00012, and for parasite gene expression P=0.0049 and P=0.00019, 
before and after adjustment respectively). Therefore we used adjusted gene expression values for all 
subsequent analyses. 
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substantially increased when comparing the subgroup of subjects with CH (the most severe 160 
phenotype, n=12) vs UM, possibly reflecting their greater severity and homogeneity of disease 161 
(Supplementary Table 2, Supplementary Figure 3).  The most highly expressed DEGs in CH relative to 162 
UM included neutrophil granule genes but also heat shock protein genes.  163 
In order to gain a greater insight into specific pathophysiological processes we examined the 164 
quantitative association of gene expression with clinical and laboratory parameters which 165 
characterise specific aspects of SM pathophysiology, namely conscious level (using the Blantyre 166 
Coma Scale, BCS), blood lactate concentration, platelet count and hemoglobin concentration 167 
(Supplementary Table 4). 738 genes were associated with BCS (Supplementary Table 4) and 168 
decreasing conscious level (lower BCS) was associated with higher expression of genes involved in 169 
the cell cycle, and lower expression of genes involved in MHC class I antigen presentation and 170 
interferon gamma signalling (Fig 2B, Supplementary Table 2). Predicted upstream regulators 171 
included estrogen receptor 1 and transglutaminase 2 (Supplementary Table 3). 1012 human genes 172 
were significantly correlated with lactate concentration (Supplementary Table 4), amongst which 173 
immune response pathways were again prominent, but a negative association between lactate and 174 
type 1 IFN signalling was particularly notable (Fig 2B, Supplementary Table 2), and the most 175 
significant predicted upstream regulators were IFN-γ, IFN-α, and TNF (Supplementary Table 3).  178 176 
genes were significantly associated with platelet count (Supplementary Table 4) and the most 177 
enriched pathways differed considerably from those in the preceding analyses (Fig 2B, 178 
Supplementary Table 2), with nucleosome assembly (predominantly histone genes), coagulation, 179 
and response to wounding genes, all negatively correlated, and the most significant predicted 180 
upstream regulators being IL13, RB transcriptional corepressor 1, and IL1RN (Supplementary Table 181 
3). No human genes were significantly correlated with hemoglobin. Taken together these results 182 
identify common transcriptional features of SM but also implicate distinct mechanisms underlying 183 
the different pathophysiological processes which can occur in SM. 184 
  185 
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187 
Volcano plot showing extent and significance of up- or down- regulation of human gene expression 188 
in SM compared with UM (red and green, P <0.05 after Benjamini-Hochberg adjustment for false 189 
discovery rate (FDR); orange and green, absolute log2-fold change (FC) in expression > 1; SM n=25, 190 
UM=21). (B) Heatmap comparing enrichment of gene ontology terms for human genes significantly 191 
differentially expressed between SM and UM or significantly associated with blood lactate, platelet 192 
count or Blantyre Coma Scale (BCS). (C) P. falciparum differential gene expression in SM compared 193 
to UM (colour coding as in (A), SM n=23, UM=20).  (D) Heatmap comparing enrichment of gene 194 
ontology terms for parasite genes significantly differentially expressed between SM and UM and or 195 
significantly associated with blood lactate or BCS. (E) Heatmap comparing gene ontology terms for 196
197 
selected neutrophil-198 
between SM (n= ) and UM (n=)    199 
) Comparison of 
related gene expression multiplied by absolute neutrophil count in blood 
(Wilcoxon )
 
human genes significantly associated with log parasite density and log PfHRP2. (F
Figure 2. Association of gene expression with features of severe malaria and parasite load. (A) 
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Parasite differential gene expression in severe malaria 200 
There were 236 parasite DEGs between SM and UM (Fig 2C, Supplementary Table 5).  201 
The parasite DEG with highest expression in SM relative to UM was PF3D7_1016300  202 
(Supplementary Table 3) which encodes a glycophorin binding protein (GBP) expressed in the 203 
cytoplasm of infected erythrocytes and which influences adhesion and rigidity of the red cell (32, 204 
33). The most down-regulated parasite DEG (with known function) in SM relative to UM was 205 
PF3D7_1222600, which encodes the AP2 domain transcription factor AP2-G. This protein controls 206 
the balance between gametocytogenesis and asexual replication, and knockout of the orthologue in 207 
P. berghei ANKA significantly enhances in vivo asexual parasite growth rate (34, 35).  As with human 208 
gene expression there were similarities in patterns of DEGs in the comparison of different clinical 209 
phenotypes of SM vs UM, and again the most DEGs were found in the comparison with the CH group 210 
(Supplementary Fig 3, Supplementary Table 5). Here the most differentially expressed parasite genes 211 
included PF3D7_0202000 (knob-associated histidine rich protein), PF3D7_1016300 (GBP), 212 
PF3D7_0201900 (erythrocyte membrane protein 3), and PF3D7_0424600 (PHIST-b protein), all of 213 
which encode proteins which interact with the erythrocyte cytoskeleton to influence cytoadhesion 214 
and deformability of the infected erythrocyte, making them highly plausible determinants of severity 215 
(33). Parasite DEGs in SM compared to UM were enriched in specific biological functions including 216 
RNA processing, protein transport, and hemoglobin catabolism (Fig 2D, Supplementary Table 6).  217 
445 parasite genes were significantly associated with BCS, and those most significantly correlated 218 
with decreasing conscious level were PF3D7_0919800 (TLD domain-containing protein), 219 
PF3D7_1133700 (FHA domain-containing protein), and PF3D7_1408200 (AP2 domain transcription 220 
factor AP2-G2), the latter two both important determinants of asexual parasite growth rate (35, 36) 221 
(Supplementary Table 7). The most enriched functions associated with BCS included transport, 222 
hemoglobin catabolism and prenylation (Fig 2D). 100 parasite genes were significantly correlated 223 
with lactate (Supplementary Table 7). The most significant was PF3D7_0201900 (encoding 224 
erythrocyte membrane protein 3, EMP3), consistent with infected erythrocyte rigidity and 225 
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cytoadhesion (32, 37, 38) being important determinants of microvascular obstruction and 226 
hyperlactatemia (39). Pathway enrichments amongst these genes differed from those most 227 
associated with BCS and included membrane docking and rRNA processing (Fig 2D and 228 
Supplementary Table 6). Few parasite genes were associated with hemoglobin concentration or 229 
platelet count (Supplementary Table 7). Taken together, these findings indicate that different 230 
patterns of parasite gene expression are associated with, and may therefore contribute to, specific 231 
aspects of host pathophysiology. 232 
In order t233 
in vitro. 61 genes were 234 
 (n=5) early ring-stage 235 
236 
237 
supplementation were PF3D7_1016300 (GBP) and PF3D7_0202000 (Knob-238 
p  the CH may 239 
with a  recent report that 240 
Plasmodium can sense and respond to the host metabolic environment (40).  241 
 242 
Effect of parasite load on host and parasite gene expression 243 
Previous studies have shown a correlation between the expression levels of host genes and 244 
circulating parasitemia (41, 42). There were significant differences in parasite load between our 245 
subjects with SM and UM (Table 1) and so we were interested to determine the extent to which this 246 
explained the differences in whole blood gene expression. Peripheral blood parasite quantification 247 
(parasite density) underestimates the total number of parasites in the body because of 248 
sequestration of parasites in the microvasculature (13, 14). The soluble parasite protein, P. 249 
falciparum histidine rich protein 2 (PfHRP2), has been used as a plasma biomarker of total parasite 250 
load (circulating plus sequestered) and is more strongly associated with severity (8, 9, 11) and death 251 
o establish whether changes in parasite gene expression might be cause or consequence of 
SM, we tested the effect of hyperlactatemia on parasite gene expression 
differentially expressed between lactate supplemented (n=4) and control
parasite cultures, particularly enriched in genes associated with transcription and RNA processing 
(Supplementary Tables 5 and 6). Surprisingly two of the genes most highly induced by lactate 
associated histidine rich 
rotein), genes which were also highly expressed in phenotype. This suggests lactate 
influence the virulence phenotype of parasites, consistent nother
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(8, 9). Therefore we examined the association of host and parasite gene expression with both 252 
circulating parasite density and PfHRP2 (restricting comparisons to subjects with data for both). We 253 
found 1886 human genes significantly (FDR P<0.05) correlated with log parasite density and 616 254 
significantly correlated with log PfHRP2 (102 common to both), whilst only 2 and 10 parasite genes 255 
were significant in the corresponding analyses (none common to both) (Supplementary Tables 4 and 256 
7). Human genes correlated with log parasite density were particularly enriched in pathways related 257 
to translation (especially exported proteins), oxidative phosphorylation, and antigen presentation 258 
(Fig 2E, Supplementary Table 2), with predicted upstream regulation by RPTOR independent 259 
companion of MTOR complex 2 (RICTOR), hepatocyte nuclear factor 4 alpha (HNF4A) and X-box 260 
binding protein 1(XBP1); Supplementary Table 3). Genes correlated with log PfHRP2 were 261 
particularly enriched in innate immune response functions (Fig2E, Supplementary Table 2), with 262 
predicted regulation by interferon-γ (IFN-γ), transglutaminase 2, and IFN-α2 (Supplementary Table 263 
3). These findings suggest that the nature of the systemic host response is associated with the 264 
localisation of parasites.  265 
We next asked to what extent the differences in gene expression between SM and UM phenotypes 266 
were dependent on parasite load. Restricting analyses to subjects with both parasite density and 267 
PfHRP2 measurements, the number of human SM vs UM DEGs remained almost unchanged after 268 
adjustment for parasite density but was reduced by 98.6% after adjustment for PfHRP2, whilst 269 
parasite DEGs changed much less after either of the same adjustments (Table 2, Supplementary 270 
Tables 1 and 5). Findings were similar when adjusting for parasite load in comparisons of each of the 271 
SM subtypes vs UM (Supplementary Tables 1 and 5). n independent 272 
dataset of CM (43), revealed 994 DEGs 273 
-associated retinopathy 274 
(Supplementary Table 1), 608 (61  DEGs after 275 
 276 
Repeating this analysis in a
human microarray gene expression in Malawian children with 
(FDR P<0.05) between children with (n=55) and without (n=17) malaria
%) DEGs after adjustment for parasite density, and no
adjustment for PfHRP2.
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Taken together the preceding findings suggest that total body parasite load, as represented by 277 
PfHRP2, is a dominant determinant of host gene expression in malaria, particularly inflammatory and 278 
immune response genes, and differences in total body parasite load drive the majority of the human 279 
280 
281 
282 
adjustment for PfHRP2 (Table 2, Supplementary Table 1). Of particular interest amongst these, 283 
MMP8 (also known as collagenase 1) is a metallopeptidase which causes endothelial barrier damage 284 
in several infection models (44, 45); AZI2 (also known as NF-Kappa-B-Activating Kinase-Associated 285 
Protein 1, NAP1) encodes a regulator of the type 1 interferon response (46), a pathway which is 286 
known to control severity of disease in rodent malaria models (47); whilst CX3CR1 is the receptor for 287 
fractalkine (a biomarker of CM in humans (48)),is expressed on subset of monocytes which are 288 
289 
290 
Parasite load was also a major driver of the associations between human gene expression and BCS, 291 
lactate, and platelet count, but its importance did vary between them (Table 2). Interestingly the few 292 
remaining genes significantly associated with lactate after adjustment for PfHRP2 included PKM 293 
(encoding the glycolytic enzyme pyruvate kinase M) and GYS1 (encoding the glycogenic enzyme 294 
glycogen synthase 1) (Supplementary Table 4), suggesting hyperlactatemia is partly associated with 295 
parasite load-independent variation in control of host glucose metabolism. The number of genes and 296 
297 
 298 
Co-expression networks of host and parasite genes 299 
Whilst independent analyses of host and parasite gene expression associations with severity are 300 
enlightening, dual-RNA sequencing can also be used to identify molecular interactions within and 301 
between species and their associations with severity (1). Expression of groups of genes with 302 
 biological functions associated with platelet count were notably less dependent on parasite load. 
gene expression differences between SM and UM. However, if genes remain associated with severity 
after adjustment for parasite load this may indicate intrinsic variation in the host response which 
particularly efficient at killing malaria parasites (49), and controls the trafficking of monocytes during 
inflammation (50).  
determines susceptibility to severe disease. In our dataset, only 13 genes remained significant after 
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common functional roles are often highly correlated and can be identified through co-expression 303 
network analysis (51). We applied this methodology to the paired host and parasite gene expression 304 
from each individual, to identify groups of genes originating from either or both species, on the basis 305 
of their correlated expression. We term these groups of genes “modules”, and we named each 306 
module according to the “hub gene” which has the greatest connectivity to other genes within the 307 
module. First we analysed all subjects together and a network with 26 modules was generated (Fig 3 308 
and Supplementary Table 8): 10 containing exclusively human genes, 5 exclusively parasite genes, 309 
and 11 with both human and parasite genes (most of these highly skewed to a single species). Only 310 
the HSPH1 (heat shock protein family H (Hsp110) member 1) module contained more than 10 genes 311 
from both human and parasite, strongly enriched in human heat shock response genes and parasite 312 
RNA metabolism genes. All modules showed significant functional enrichments regardless of host or 313 
parasite origin. The composite expression of genes within a module can be described by a module 314 
eigengene value (52) and there were significant associations between module eigengene values and 315 
severity, parasite load, BCS and laboratory parameters (Figure 3). Some host-dominated and 316 
parasite-dominated modules were also highly correlated with each other, most notably the RPL24 317 
(ribosomal protein L24) module (highly enriched in translation pathways) was strongly correlated 318 
with the remarkably homologous PF3D7_0721600 (putative 40S ribosomal protein S5) parasite 319 
module. We excluded read mapping errors as an explanation for this, and suggest that this indicates 320 
co-regulation of conserved host and parasite translation machinery. Furthermore, most of these 321 
genes were also differentially expressed between SM and UM. Thi indicate a 322 
molecular arms race for defence and survival, 323 
respectively. In excess, these proteins may contribute to  in SM.  324 
  325 
s association may 
between parasite and host to synthesise proteins 
tissue damage
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 326 
Figure 3. Interspecies gene expression modules and their associations with severity.  Circos plot 327 
showing gene expression modules obtained from whole genome correlation network analysis using 328 
expression of all human and parasite genes from each subject (SM, n=22; UM, n=19) as the input. 329 
From outside to inside: labels, hub gene and most enriched GO term (with enrichment P-value) for 330 
each module; track 1, module eigengene value for each subject; track 2, clinical phenotype (Red=CH, 331 
Orange=CM, Green=HL, Yellow=UM); track 3, hub gene expression (log CPM) for each subject; track 332 
4, heatmap for correlation with laboratory measurements (clockwise, blocks: log parasite density, 333 
log PfHRP2, lactate, platelets, hemoglobin, BCS; colour intensity represents correlation coefficient as 334 
shown in colour key); track 5, module size and composition (length proportional to number of genes 335 
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in module; red, human genes; blue, parasite genes); polygons connect modules with significant (FDR 336 
P<0.01) Pearson correlation between eigengene values (width proportional to -log10 FDR P-value; 337 
red=positive correlation, blue=negative correlation)   338 
 339 
  340 
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Association of co-expression modules with severity 341 
Co-expression network modules can be used as units of analysis, affording considerable dimension 342 
reduction for whole-genome expression data. We used module eigengene values (51, 52) and 343 
parasite load (with which many modules were correlated, Fig 3) in linear regression models to 344 
determine the best within-sample predictors of severity, starting with all significant univariate 345 
associations and proceeding by backward selection (Supplementary Table 9). The best multivariate 346 
model combined MMP8, OAS1 (2'-5'-oligoadenylate synthetase 1) and LYSMD3 (LysM, putative 347 
peptidoglycan-binding, domain containing 3) module eigengenes, but not parasite load. Interestingly 348 
these modules represent distinct aspects of the immune response: the MMP8 module, highly 349 
enriched in defence response genes with predicted upstream regulators CEBPA (CCAAT/enhancer 350 
binding protein alpha, a myeloid transcription factor) and CSF3, likely reflects granulopoiesis (31); 351 
the OAS1 module is highly enriched for type 1 IFN response genes; the small LYSMD3 module, with 352 
limited GO enrichment, contains a functional network around IFN-γ (Supplementary Figure 4). The 353 
direction of association of the OAS1 module with severity changed from negative in univariate 354 
analysis to positive in the multivariate analysis, suggesting that inadequate suppression of the type-1 355 
IFN response in conjunction with upregulation of granulopoiesis and IFN-γ signalling may contribute 356 
to pathogenesis.   357 
 358 
Differential co-expression in severe malaria 359 
Considering all subjects together for generation of co-expression networks maximises power to 360 
detect consistently co-regulated genes but may not identify sets of genes where co-regulation is 361 
altered by severity. For this reason we also created separate co-expression networks for UM and SM 362 
and compared the modules to identify differential co-expression (Fig 4, Supplementary Table 10). 363 
Eight modules showed significant preservation between networks, seven were partially preserved, 364 
and two were unique to SM (Figure 4A). Partial preservation was common amongst modules 365 
comprised predominantly from human or parasite genes (Figure 4A,B), and module preservation was 366 
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not dependent on the proportion of module genes differentially expressed between SM and UM 367 
(Figure 4A,C).  A MMP8 module was identified (exclusively human genes, many encoding neutrophil 368 
granule and phagosome components) uniquely in SM subjects, and 38% of its member genes were 369 
DEGs in the comparison between SM and UM. The module was enriched in host defence functions 370 
(Supplementary Table 10) and predicted to be regulated by CEBPA, CSF3 and TNF. These findings 371 
strongly suggest the MMP8 module represents emergency granulopoiesis (31) and mark this as a 372 
specific feature of SM. The TIPRL (TOR Signaling Pathway Regulator) module (99.2% human genes) 373 
was also unique to SM but contained very few (1.3%) DEGs, had limited GO enrichment 374 
(Supplementary Table 10), and the most significant predicted upstream regulator was the 375 
transcription factor HNF4A. Both TIPRL and HNF4A have regulatory roles in metabolic, inflammatory 376 
and apoptosis signal pathways, so the minimal change in expression of this module may represent 377 
an aberrant response in SM (53, 54). Amongst the partially preserved modules we observed that 378 
host and parasite translation pathways were more tightly co-regulated in SM than UM, genes being 379 
distributed across fewer modules in SM (Fig 4A, Supplementary Table 10). This once again suggests 380 
that there is an interaction between these processes that is associated with severity. 381 
  382 
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 383 
Figure 4. Severity-associated differential co-expression within the interspecies gene expression 384 
network. (A-C) Cytoscape visualisation of merged co-expression networks derived separately from 385 
SM (n=22) and UM (n=19). Networks were merged such that genes found in both sub-networks 386 
(represented as arrow-shaped, larger-sized nodes) are connected to genes found in only one sub-387 
network (represented as circular-shaped and smaller-sized nodes). (A) Genes and gene clusters are 388 
coloured and annotated by module, species, most enriched gene ontology terms, and conservation 389 
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between sub-networks (preserved, module pairs from SM and UM sub-networks display highly 390 
significant overlap with each other and much less significant overlap with other modules; partially 391 
preserved, module clusters display significant overlaps with two or more modules in the other sub-392 
network; unique, gene clustering only found in one sub-network); genes in black do not belong to 393 
any characterized module. (B) Identical network layout with genes coloured by species (red, human; 394 
blue, P. falciparum). (C) Identical network layout with genes coloured by whether they are 395 
significantly differentially expressed in SM vs UM (red, human; blue, P. falciparum; black, not 396 
differentially expressed).   397 
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Interaction of parasite and host gene expression accounting for parasite load 398 
We sought to integrate pathogen load into analysis of interaction between host and parasite gene 399 
expression. To reduce dimensionality we generated human-only gene expression modules from all 400 
subjects (Supplementary Table 11), identified those modules significantly associated with severity, 401 
and then identified parasite genes with significant (FDR P <0.05) pairwise associations with these 402 
modules in a linear model accounting for log PfHRP2.  The human modules associated with severity 403 
were similar to those identified in preceding analyses (Table 3). The most significantly associated 404 
parasite genes and the most enriched parasite GO terms were those involved in RNA processing and 405 
translation (Table 3, Supplementary Table 11), suggesting that these processes in the parasite drive 406 
multiple aspects of the host transcriptional response independent of their effect on parasite load.     407 
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Neutrophil-related proteins in plasma 
The most differentially expressed genes in comparisons between SM and UM encode neutrophil 
granule proteins. Relationships between transcription, translation, storage and release of granule 
proteins are expected to be complex, but we sought evidence of correlation between gene 
expression and circulating levels. In subjects with residual stored plasma we found significant 
correlations between gene expression and plasma concentrations of defensin A3 (P = 0.0049, rho 
=0.47, n=34) and elastase (P = 0.045, rho 0.35, n=34) (Supplementary Figure 5). MMP8 expression 
was significantly correlated with plasma levels in subjects with SM (P = 0.02, rho = 0.59 , n=15), but 
not in UM (P = 0.37, rho = -0.21, n=20) or all subjects combined (P=0.88 , rho=-0.026, n=35). GCSF 
was predicted as a major upstream regulator of genes in the MMP8 module. We found that plasma 
GCSF concentrations were significantly correlated with the eigengene values for this module (P = 
0.0030, rho 0.64, n=19). We tested whether neutrophil degranulation occurred in response to 
parasite material by stimulating healthy donor blood cells with P. falciparum schizont lysate, and 
detected significant increases in MMP8 release, reaching similar concentrations to those observed in 
plasma during malaria (Supplementary Figure 5). 
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 424 
Discussion  425 
We used dual-RNA sequencing to identify simultaneous host and parasite gene expression and their 426 
systemic interactions associated with severity of P. falciparum malaria in humans. Our findings 427 
establish this as a paradigm for integrated understanding of infectious diseases and make a strong 428 
case that neither host nor pathogen should be studied in isolation.  429 
We have identified many plausible associations between gene expression and features of severity, 430 
providing an unbiased insight into the pathogenesis of SM (Figure 5). One of our most striking 431 
findings was the overriding effect of parasite load on differences in human gene expression between 432 
SM and UM. Previous studies have examined the association between human gene expression and 433 
circulating parasitemia (23, 41, 42), but we found that estimation of total body parasite load was 434 
necessary to appreciate the full effect on host response. Our findings imply that the host response in 435 
SM is not excessive per se, but rather that it is an appropriate host response to an excessive 436 
pathogen load. This has important implications for malaria research and likely other infectious 437 
disease, immunology, and pathogenesis research in humans. Without accounting for pathogen load, 438 
associations between host factors (such as genetic variants or comorbidities) and severity of 439 
infection may well be misinterpreted. Unfortunately, total body pathogen load is much harder to 440 
measure in other infections in humans where pathogens are not restricted to the blood (55).  441 
  442 
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 443 
Figure 5. Host pathogen- in severe malaria revealed through dual RNA-sequencing. 444 
Selected biological ,  445 
associated with SM. lood transcriptional 446 
response. Parasite genes and biophysical 447 
properties of the erythrocyte SM. Translation pathway gene expression in parasites 448 
correlates with expression of similar  in human cells, suggesting that a “molecular arms race”. 449 
Sequestration of high concentrations cytoadherent and rigid parasitized eryrthrocytes in small 450 
blood vessels likely stimulate  neutrophil degranulation, NETosis, and vascular 451 
endothelial activation,  coagulation and thrombocytopenia, worsening 452 
microvascular dysfunction, and pro . 453 
neutrop  amplifying the pathological process. Subsets of host and 454 
parasite genes assoc  point to differing pathophysiology of 455 
. 456 
, while 457 
. 458 
by altering gene expression to evade the host response. 459 
interactions 
processes are illustrated
High parasite load is the major driver of the human whole b
regulating asexual growth rate, sexual differentiation, 
associate with 
genes
of 
s processes such as
which then drive
inflammatory responses
hil granule production, potentially
iated with either hyperlactatemia or coma
these clinical manifestations For example, prenylation may enhance erythrocyte membrane 
presentation of parasite proteins needed for sequestration in the brain vasculature
proinflammatory signalling may drive hyperlactatemia through aerobic glycolysis in immune cells
Parasites may respond to changes in lactate 
GCSF promotes granulopoiesis and 
representing human and parasite gene expression
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the present study, non-bold text identifies 460 
specifically investigated in the present study. 461 
  462 
Bold text identifies biological processes supported by 
processes which are known to occur in malaria but not 
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We found that specific sets of host and parasite genes were associated with different 463 
pathophysiological consequences of malaria associations was limited in 464 
the smallest subgroup . Distinct sets of host genes were correlated with BCS, lactate 465 
concentration and platelet count. Hyperlactatemia in malaria is often ascribed to anaerobic 466 
metabolism arising from microvascular obstruction by adherent and rigid parasitized erythrocytes (4, 467 
39).  mbers of the var, rif 468 
and stevor gene families  (14) 469 
-based quantification. Despite this limitation still 470 
found associations between and severity and in vivo variation in the 471 
expression of  modify the biophysical properties of the infected 472 
. Some variation in ne expression may have a genetic basis (56) but our in 473 
vitro data suggests that it may also  a response to the host environment.  474 
The human genes most correlated with lactate were immune response-related, suggesting that 475 
inflammation and perhaps its effect on glycolysis may also be involved (57, 58). If lactate production 476 
associated with the strength of the host response then the changes in expression of parasite genes 477 
which might favour sequestration and evasion of innate immune cells in response to lactate 478 
exposure could be viewed as a parasite survival strategy. Cerebral malaria in humans is usually 479 
ascribed to parasite sequestration in the cerebral microvasculature, but the association between BCS 480 
and antigen presentation via MHC class 1, interferon-γ, and type-1 interferon signalling, would be 481 
consistent with the localisation of these immunopathological mechanisms away from the blood and 482 
into the brain microvasculature as seen in rodent experimental cerebral malaria (15, 16, 59). 483 
Thromobocytopenia is almost invariable in malaria and its mechanism is poorly understood (7). Our 484 
findings implicate the well-recognised activation of endothelial surfaces and coagulation pathways in 485 
malaria (7) as a cause, but also lead us to suspect a role for histone-induced thrombocytopenia (60, 486 
61).  487 
, albeit that power to detect 
analyses
These properties are partly determined by the expression of particular me
, which we did not include in our analysis because the extreme degree 
of polymorphism prevents reference genome
lactate concentration 
other parasite genes known to
parasite ge
occur as
we 
erythrocyte
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Many of our results converge on a putative role for neutrophils in SM. Different analytical 488 
approaches repeatedly identified the association of genes encoding neutrophil granules (such as 489 
MMP8, OLFM4, DEFA3, ELANE) and upstream regulators of granulopoiesis (CSF3 and CEBPA) with 490 
severe outcomes.  Granule proteins are enriched in immature neutrophils (31, 62) which are 491 
mobilised from the bone marrow to the circulation in malaria (63, 64), and there is plentiful 492 
evidence that neutrophil degranulation occurs in SM (43, 65). Release of neutrophil granule proteins 493 
can be highly damaging to host tissues (62), and increased production and release of these proteins 494 
could contribute to many of the pathological features of SM. Both neutrophil granule proteins and 495 
histones are released into the circulation during production of neutrophil extracellular traps (NETs) 496 
(62, 66), a phenomenon which has been described in malaria (64). It is noteworthy that similar 497 
neutrophil-related signatures are not reported in the whole blood transcriptomes of rodent models 498 
which have been examined to date (42, 67), creating a challenge for experimental validation. 499 
However neutrophil depletion has been shown to prevent experimental cerebral malaria (68), and 500 
whilst this is not a viable therapeutic option in humans, pharmacological inhibitors of specific 501 
neutrophil functions such as NETosis are being evaluated (66). 502 
We observed an intriguing relationship between type-1 IFN responses and severity, which may help 503 
to tie together data from previous observations in humans and animal models. In a small study, 504 
expression of type-1 IFN response genes in blood from UM was higher than in SM, leading to the 505 
suggestion that this may be protective against developing SM (69). However we found that type-1 506 
IFN response genes were negatively correlated with parasite load, suggesting down-regulation with 507 
increasing parasite load (and severity) is a more likely explanation. When we performed multivariate 508 
analyses using gene expression modules to explain severity, our results suggested that insufficient 509 
suppression of type-1 IFN signalling was in fact associated with severity. This would be more 510 
consistent with results in several animal models where genetic or antibody-mediated ablation of 511 
type-1 IFN signalling improves outcome (70-73).   512 
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Very few parasite genes correlated significantly with parasite load at the time of clinical presentation 513 
which may be a consequence of its dynamic nature, determined by parasite growth rate, the 514 
number of replication cycles in the host (duration of infection), and its reciprocal interaction the 515 
constraining host response that it stimulates. Thus lower expression of the gene encoding ApiAP2-G 516 
in SM may well cause increased asexual parasite growth rate (34) and make SM more likely, without 517 
this gene exhibiting any significant correlation with parasite load. It may also seem paradoxical that 518 
this gene is down-regulated in SM when gametocytes are usually more common in SM (30), a trend 519 
we observed in our data. Development of mature gametocytes takes 10-12 days, for much of which 520 
they are not in the systemic circulation (74), so we speculate that the mature gametocytes detected 521 
at the time of clinical presentation may reflect preferential gametocytogenesis early in infection and 522 
perhaps a subsequent reduction in ApiAP2-G promotes enhanced asexual replication and severe 523 
disease.  524 
We noted that both human and parasite translation pathways were associated with SM, and these 525 
pathways showed the strongest evidence of interaction between species, with co-regulation 526 
appearing tighter in more severe disease. Increased translation is important for production of host 527 
defence effector proteins (75) and parasite proteins which enable survival (76) and it is feasible that 528 
these processes drive each other. This raises the intriguing question of whether addition of a 529 
translation inhibiting anti-malarial such as mefloquine (77) to standard artesunate treatment may 530 
have added benefit in SM.  531 
The differences in human and parasite gene expression between SM and UM were much clearer 532 
after adjusting for heterogeneity of leukocyte population and parasite developmental stage. 533 
Although the importance of accounting for such variation is well recognised (24), it is rarely done in 534 
infectious disease transcriptomic studies. 535 
have shown that this has a major impact on 536 
cal phenotype (78, 79). The data 537 
we have generated and comprehensive analyses we have performed following these adjustments 538 
Several studies have used alternative methods to account 
for parasite developmental stage distribution and 
observed associations between parasite gene expression and clini
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provide a unique and valuable resource for the research community. Whilst we cannot establish 539 
causation from an observational study such as this, our findings should be launch points for future 540 
work assessing the implicated mechanisms and their potential as targets for adjunctive therapies. 541 
The identification of multiple and sometimes distinct host and parasite mechanisms associated with 542 
differing aspects of pathophysiology potentially bodes ill for adjunctive therapies, which might need 543 
to have multiple targets and perhaps be personalized to differing SM manifestations. However the 544 
common association of neutrophil granule protein genes with all SM manifestations suggests that 545 
targeting neutrophil function may be a therapeutic strategy in the future.  546 
  547 
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Materials and Methods 548 
Experimental design 549 
The primary aim of the study was to analyse differential human and parasite gene expression 550 
between children with SM and UM and to determine its association with parasite load. Secondary 551 
aims were 1) to analyse differences in gene expression associated with different severe malaria 552 
syndromes and with continuous variables which are markers of pathophysiology, 2) to evaluate co-553 
expression of host and parasite genes, and 3) to evaluate differential co-expression associated with 554 
SM.  Sample size was determined pragmatically based on the availability of suitable samples with 555 
necessary clinical and laboratory data, since there is no established method to determine optimal 556 
sample size for dual RNA-Seq studies. We aimed to achieve close to 30 million mapped human reads 557 
and 5 million mapped parasite reads per sample and calculated the likely number of reads required 558 
to achieve this based on the percentage parasitemia and the likely amount of RNA per ring-stage 559 
parasite (27). From available RNA samples we aimed to have roughly equal numbers of severe and 560 
uncomplicated malaria cases and within the severe malaria cases we aimed to have eight subjects 561 
with each phenotype. After assessment of RNA quantity and quality some samples were unsuitable 562 
for RNA-sequencing which resulted in the final composition of groups being slightly unbalanced. 563 
Subjects and samples  564 
Gambian children (under 16 years old) with P. falciparum malaria were recruited from three peri-565 
urban health centres, The MRC Gate Clinic, Brikama Health Centre, and The Jammeh Foundation for 566 
Peace Hospital, Serekunda, as part of a larger study of severe malaria (11, 80, 81). Informed consent 567 
was obtained from the child’s parent or legal guardian for collection and subsequent use of samples. 568 
The study was approved by the Gambian Government / MRC Laboratories Joint Ethics Committee. 569 
All children underwent full clinical examination and were managed in accordance with the Gambian 570 
government guidelines. Malaria was defined by the occurrence of fever in the last 48 hours before 571 
recruitment and >5000 asexual parasites/μL in the peripheral blood. Subjects were further 572 
categorized into different severe malaria phenotypes using modified World Health Organization 573 
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criteria: cerebral malaria (CM) was defined as Blantyre Coma Score (BCS) of 1 or 2, or a BCS of 3 if 574 
the motor response was 1, AND no hypoglycaemia, no rapid improvement in response to fluid 575 
resuscitation, no suspicion of meningitis; hyperlactatemia (HL), blood lactate concentration > 576 
5mmol/L; both CM and HL (CH) (11). At the time of presentation to the clinic, prior to any 577 
antimalarial treatment or blood transfusion, capillary blood was used for measurement of lactate 578 
and glucose concentrations and thick and thin blood films, venous blood was collected into EDTA for 579 
sickle cell screen and full blood count, PAXgene blood RNA tube (BD), and sodium heparin (BD) for 580 
plasma separation (80). Parasitemia was calculated using 50 high power fields on Giemsa-stained 581 
thin blood smears. Plasma P. falciparum histidine-rich protein II (PfHRP2) was measured by ELISA 582 
(Cellabs) (11). Full blood counts, including 583 
584 
MedonicTM  585 
For the present study we used 46 subjects selected from those with ≥1µg RNA available which 586 
showed no / minimal evidence of degradation on visual inspection of a Bioanalyser (Agilent) trace 587 
(RNA integrity number calculations are not valid for dual species RNA analysis). To reduce potential 588 
confounding we aimed to frequency match subjects between SM and UM groups as closely as 589 
possible by age and gender, and if there remained a choice of samples available we selected those 590 
with the most complete additional clinical and laboratory data. For UM samples we aimed to include 591 
an equal number with parasitemia above and below 5% (to maximise the chance of obtaining 592 
parasite reads in some of the subjects). For SM samples we aimed to include subjects with each of 593 
the common SM phenotypes seen in this part of the Gambia in approximately equal numbers, 594 
although final numbers were determined by availability and quality of RNA. Detailed information 595 
about the study subjects is shown in Supplementary Table 1 and Supplementary Dataset 1. 596 
Characteristics were compared between subject groups using one-way ANOVA for continuous data 597 
and Fisher’s exact test for categorical data. 598 
RNA sequencing  599 
hemoglobin concentration, platelet count, total white cell 
count and three part differential (neutrophil, lymphocyte and monocyte counts) were made using a 
hematology analyser (Clinical Diagnostics Solutions, Inc).
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Total RNA was extracted using the PAXgene Blood RNA kit (BD). Libraries were prepared from 1μg of 600 
total RNA using the ScriptSeq v2 RNA-seq library preparation kit (Illumina) with additional steps to 601 
remove ribosmal RNA (rRNA) and globin messenger RNA (mRNA) using the Globin-Zero Gold kit 602 
(Epicentre). Strand-specific libraries were sequenced using the 2x100 bp protocol with an Illumina 603 
HiSeq 2500 instrument. In order to eliminate batch effects, samples were randomized for the order 604 
of library preparation. For sequencing, 5-6 samples were run per lane, and each lane contained at 605 
least one sample from each disease type, randomly allocated in a block design. Library preparation 606 
and sequencing were carried out by Exeter University sequencing service. 607 
Genomes and RNA annotations  608 
Human reference genome (hg38) was obtained from UCSC genome browser 609 
(http://genome.ucsc.edu/) and P. falciparum reference genome (release 24) was obtained from 610 
PlasmoDB (http://plasmodb.org/). Human gene annotation was obtained from GENCODE (release 611 
22) (http://gencodegenes.org/releases/) and P. falciparum gene annotation from PlasmoDB (release 612 
24) (http://plasmodb.org). 613 
Read Mapping and quantification  614 
RNA-seq data was mapped to the combined genomic index containing both human and P. 615 
falciparum genomes using the splice-aware STAR aligner, allowing up to 8 mismatches for each 616 
paired-end read (82). Reads were extracted from the output BAM file to separate parasite-mapped 617 
reads from human-mapped reads. Reads mapping to both genomes were counted for each sample 618 
and removed. BAM files were sorted, read groups replaced with a single new read group and all 619 
reads assigned to it, and indexed to run RNA-SeQC, a tool for computing quality control metrics for 620 
RNA-seq data (83). HTSeq-count was used to count the reads mapped to exons with the parameter 621 
“-m union” (84). Only uniquely mapping reads were counted. 622 
Since our analysis of P. falciparum gene expression was reliant on a reference genome, families of 623 
highly polymorphic var, stevor, and rifin genes were removed from downstream analyses as these 624 
exhibit great sequence diversity between parasites and are likely to be incorrectly characterized (14). 625 
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Additional highly polymorphic regions within the P. falciparum genome which might also be 626 
incorrectly characterized were identified using schizont stage RNA-seq data from 9 clinical isolates 627 
(Duffy et al., manuscript submitted). In total, 139 genes were identified with highly polymorphic 628 
regions. A reference GTF file containing P. falciparum gene annotations was modified to remove 629 
these regions without removing the genes, and the resulting read count data generated using the 630 
modified GTF file was used for downstream analysis.  631 
Outlier identification  632 
With the R package edgeR, raw read counts of each data set were normalized using a trimmed mean 633 
of M-values (TMM), which takes into account the library size and the RNA composition of the input 634 
data (85). A multi-dimensional scaling (MDS) plot was used to identify the distances between 635 
samples that correspond to leading biological coefficient of variation. Up to the 6th dimension of 636 
MDS was plotted to fully observe the variation between samples, with two dimensions visualized at 637 
a time in scatter plot format. Three parasite samples were consistently found to be positioned away 638 
from other samples in each pair of dimensions, indicating outliers. This was further supported by low 639 
correlations observed between either of these outliers with other samples. These three samples 640 
were excluded from further parasite gene expression analysis: one sample (HL_478) had very low 641 
parasite reads making estimation of gene expression impossible and the other two samples (CH_285 642 
and UM_589) were conspicuous outliers on MDS plots, possibly due to imperfect library preparation. 643 
Deconvolution analysis  644 
inter-individual 645 
circulating parasites we 646 
e contribution of each cell type and parasite stage to the RNA we detected 647 
, and then adjust for the effect of cell-mixture when analysing the association 648 
. We expected that this would particularly enhance the 649 
650 
Deconvolution analysis was performed on RNA-seq data 651 
In order to study the variations in gene expression beyond those attributable to 
variation in the proportion of different cell types or developmental stage of 
sought to determine th
from whole blood
between gene expression and severity
detection of cellular responses to external stimuli (upstream regulators) which may otherwise be 
masked by variation in cell proportions.
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using CellCODE (25). This uses a multi-step statistical framework to compute the relative differences 652 
in cell proportion represented as surrogate proportion variables (SPVs). It requires a reference data 653 
set that contains gene expression profiles for each cell type of interest. Five major immune cell 654 
populations were selected from Immune Response In Silico (IRIS) (86) to constitute the human 655 
reference data set: neutrophil, monocyte, CD4+ T-cell, CD8+ T-cell, and B-cell. Fragments Per 656 
Kilobase of transcript per Million mapped reads (FPKM) values were calculated from human RNA-seq 657 
data and log-transformed to simulate a microarray data set. For the parasite reference data set, 658 
RNA-seq data sets were obtained for four specific stages in the parasite asexual and sexual stage (0 659 
hour, 24 hour, 48 hour, and gametocyte stage V) (26, 28), normalized by relative library sizes of 660 
samples (i.e. size factors) using edgeR. An identical normalization method was also applied for the 661 
input parasite RNA-seq data. A trial-and-error approach was taken to obtain the optimum SPV values 662 
for each cell-type. For human deconvolution, a cutoff value of 1.2 and a maximum number of marker 663 
genes of 50 appeared optimal. For parasite deconvolution, a cutoff value of 1.7 and a maximum 664 
number of marker genes of 50 appeared optimal. 665 
Validation of CellCODE for P. falciparum developmental stage deconvolution (for which its use has 666 
not previously been reported) was performed by comparison with previously reported “stage-667 
specific” marker genes (29) and by assessing performance in synthetic data sets constructed by 668 
mixing together in varying proportions randomly selected reads from RNA-seq reference datasets 669 
(26, 28) of the different parasite developmental stages.  670 
e clustering of subjects based on global gene expression was 671 
672 
   673 
In order to examine the mportance of variation in cell numbers as a component of the 674 
675 
-specific expression. We multiplied normalized expression 676 
The effect of adjustment for SPVs on th
assessed using multivariate ANOVA to compare the first 10 principal components of gene expression 
in SM vs UM subjects, before and after adjustment for SPVs.
potential i
several human genes with relatively cell
host response to infection, we examined the intensity of expression per unit volume of blood of 
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( to give a composite measure 677 
.    678 
Differential gene expression and regression analyses 679 
Prior to carrying out any downstream analyses genes with very low TMM-normalized read counts (< 680 
5 counts-per-million (cpm) in < 3 samples and undetected in the remainder) were excluded. The 681 
generalized linear model (glm) tool in edgeR was employed to perform differential gene expression 682 
analysis (DGEA) between disease groups with adjustment for leukocyte and parasite SPVs, and in 683 
subsequent analyses additional adjustment for log parasite density and log PfHRP2.  684 
Linear regression analysis was performed in edgeR to identify genes significantly associated with 685 
clinical variables of interest. Input gene expression values included adjustment for SPVs. The 686 
variables considered were: log PfHRP2, log parasite density, lactate concentration, platelet counts, 687 
and hemoglobin concentration. Additional analysis for lactate, platelets and hemoglobin were 688 
conducted including adjustment for log parasite density and log PfHRP2. Association with BCS was 689 
assessed using ordinal linear regression with the R package polr, followed by chi-squared test to 690 
compare log likelihood values of the gene models with those of a model fitted with a constant. 691 
In both DGEA and linear regression analyses, false Discovery Rate (FDR) was computed for each 692 
individual analysis using the Benjamini-Hochberg procedure (87). Genes with FDR below 0.05 were 693 
considered to be differentially expressed. 694 
Gene ontology and KEGG pathway enrichment analysis 695 
Gene ontology (GO) terms for genes were obtained from Bioconductor package “org.Hs.eg.db” for 696 
human and “org.Pf.plasmo.db” for parasite. Input gene lists were significantly differentially 697 
expressed genes or genes that were significantly associated with laboratory variables. Fisher’s exact 698 
test was used to identify significantly over-represented GO terms from these gene lists. The 699 
background sets for each species consisted of all expressed genes detected in the data set with the 700 
exclusion of those with very low expression as described above. Enrichment analysis for biological 701 
FPKM) of each gene after deconvolution by the absolute cell count 
representing expression per mL of blood
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process terms was carried out using the "goana()" function in edgeR. The least redundant GO terms 702 
with greatest significance in each analysis were identified for reporting using the tool REVIGO (88). 703 
Ingenuity Pathway Analysis (Qiagen) was used for prediction of upstream regulators of groups of 704 
differentially expressed genes, and to identify functional networks.  705 
Construction of a co-expression network 706 
The weighted gene co-expression network analysis (WGCNA) tool was used to construct a gene co-707 
expression network (52). The input data for WGCNA was read counts for each gene feature 708 
normalized using TMM method and then adjusted for SPVs using the command 709 
"removeBatchEffect()" from the R package edgeR. In order to comprehensively study the 710 
relationships between genes, three separate sets of networks were created. For the first two, paired 711 
human and parasite expression data were analyzed together as a single set of genes for each 712 
subject.  We created one network using all samples from SM and UM groups at the same time, and 713 
the other with two separate sub-networks keeping SM and UM groups separate. For the third 714 
network we used only human genes for the combined SM and UM subjects. Networks were 715 
generated following the WGCNA tool guidelines: 716 
1) Hierarchical clustering was performed at a sample level to detect outliers based on the WGCNA 717 
tool threshold. If outliers were identified they were removed from the subsequent network 718 
generation (HL_171 and UM_492 were removed from combined networks). 719 
2) An appropriate soft-thresholding power (b) was chosen by applying the scale-free topology 720 
criterion. This was such that the power value enables the resulting gene network to satisfy the scale-721 
free topology of approximately (R2 > 0.80). 722 
3) Adjacency, which represents the connection strength of two genes in a network, was calculated. 723 
Co-expression similarity was calculated by taking the absolute value of the correlation coefficient, 724 
multiplying by 0.5 and adding 0.5 to create a signed network, where the presence of strongly 725 
negatively correlated gene pairs is downsized. 726 
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4) The adjacency matrix was transformed into a topological overlap matrix (TOM) in order to 727 
minimize the effects of spurious associations and noise in the network. 728 
5) Hierarchical clustering on TOM dissimilarity was done to create hierarchical clustering tree of 729 
genes. 730 
6) The dynamic tree cut method was used to group the genes that are highly correlated with one 731 
another into gene modules where minimum module size and the tree height at which genes below 732 
the height is grouped together were specified.  733 
7) Module eigengene values for each module were calculated, which represents the overall gene 734 
expression profile of a module. Correlation analysis between modules was performed using 735 
eigengene values to identify modules with high similarity (R>0.75), which were then merged 736 
together. 737 
The resulting network consisted of genes (represented as nodes in the network) and correlations 738 
between genes (represented as edges in the network), and highly correlated genes grouped 739 
together into modules. To characterize the gene network, several analysis steps were carried out. 740 
The most connected genes in each module were identified as the hub genes. Pearson correlation 741 
analysis between module eigengene values and clinical variables was performed to identify gene 742 
clusters that are highly associated with clinical traits (Spearmann correlation was used for BCS). 743 
Gene set enrichment analysis was performed on each module to identify significantly enriched GO 744 
terms. This data was summarised using OmicCircos (89).  745 
From two separate sub-networks generated from SM and UM groups respectively, the preservation 746 
of gene connections across SM and UM groups was determined by assessing an overlap of genes for 747 
each module pair (from SM and UM sub-networks respectively), the significance of overlap was 748 
measured using the hypergeometric test. For each significantly preserved module pair, the hub 749 
genes and the significantly enriched GO terms were compared. 750 
The gene network was exported to Cytoscape (http://www.cytoscape.org/) for visualisation. Only 751 
gene pairs with adjacency value of 0.03 or higher were exported to remove genes with low 752 
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connections from the network visualization. SM and UM sub-networks were exported separately 753 
and subsequently combined into a single network using the Cytoscape embedded tool "Merge". By 754 
doing so, duplicate genes representing overlap between SM and UM sub-networks were removed, 755 
and connections between genes remained intact such that genes that can only be found on SM sub-756 
network and also connected to the genes that can be found on both networks were not connected 757 
to the genes that can be found on UM sub-network and also connected to the same overlapping 758 
genes.  759 
Correlation analysis between human gene co-expression module eigengene values and parasite gene 760 
expression values with adjustment for parasite load was performed using the glm package in R, using 761 
only human modules with significant difference in module eigengene values between SM and UM 762 
(P<0.05). Gene set enrichment analysis was then performed on significantly correlated parasite 763 
genes (FDR-adjusted P<0.05) from correlations with each module to identify significantly enriched 764 
GO terms. 765 
Logistic regression for association of module eigengenes with severity 766 
Logistic regression was performed using the glm package in R to identify module eigengene values 767 
with univariate association with severity. All modules with significant univariate associations 768 
(P<0.01) in addition to log PfHRP2 concentration were used in backward selection to identify the 769 
best multivariate model in which all terms were significant. 770 
 771 
P. falciparum 3D7 -5% haematocrit in RPMI-1640 772 
(without L- ES) (Sigma) supplemented with 5 g/liter Albumax II (Invitrogen), 147 773 
-glutamine,10 mM D-glucose in 5% CO2 and low oxygen (1% or 5%) at 37 774 
°C. Parasites were at early ring stage through a combination of Percoll & sorbitol 775 
-776 
777 
 control, RNA sequencing and 778 
Lactate supplementation of parasite cultures
strain was grown in human  A+ erythrocytes at 1
glutamine, with HEP
M hypoxanthine, 2 mM L
synchronised 
treatments and adjusted to 5% parasitemia immediately prior to supplementation with sodium L
15mM lactate or control medium. After 5h erythrocytes were pelleted, adjusted to 50% haematocrit 
and transferred to Paxgene tubes (Qiagen). RNA extraction, quality
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779 
were performed as described above, with the exception that a 780 
.  781 
Micr  782 
Published microarray gene expression data, Gene Expression Omnibus GSE72058 (43), was 783 
 the contribution of parasite load to differential gene expression between cerebral 784 
Reanalysis was restricted to subjects with parasite density and PfHRP2 785 
kindly provided by Johanna Daily, Albert Einstein College of Medicine): 55 786 
-positive and 17 retinopathy-negative cerebral malaria cases. Deconvolution and 787 
nt for cell mixture was performed using CellCODE as described above. DGEA was 788 
log parasite density or log 789 
  790 
 791 
Sc  from tightly synchronized P. falciparum 3D7 parasites by Percoll gradient 792 
793 
and -thaw cycles to generate lysate. Whole blood was collected from 794 
8 healthy adult donors into sodium heparin tubes, diluted 1:1 in RPMI, and incubated overnight with 795 
rnatant was collected for further analysis. 796 
P  797 
P were measured in stored plasma samples collected on the day of clinical presentation or 798 
s using ELISAs according to the manufacturers’ instructions: MMP8, human 799 
, and defensin A3 (Cloud Clone). Spearman correlation was 800 
ns between plasma proteins concentrations, gene expression and module 801 
  802 
  803 
analysis including deconvolution of parasite developmental stage, adjustment for SPVs and 
differential expression analysis 
2x125bp sequencing protocol was used
oarray dataset analysis
human 
used to assess
malaria phenotypes. 
measurements (
retinopathy
adjustme
performed using Limma (for microarray) with and without adjustment for 
PfHRP2.
Whole blood stimulation assay
hizonts were enriched
centrifugation. The 
subjected to three rapid freeze
or without schizont lysate (1:10). Supe
rotein measurements
roteins 
culture supernatant
neutrophil elastase, GCSF (all Abcam)
used to assess correlatio
eigengene values.
schizont pellet (~80% parasitemia) was re-suspended in RPMI to 50% hematocrit 
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 830 
Supplementary Table 9. Univariate and multivariate associations of module eigengene values and 831 
parasite load with severity. 832 
  833 
Supplementary Table 10. Summary and overlap of whole genome correlation sub-networks for 834 
severe and uncomplicated malaria.  835 
 836 
Supplementary Table 11. Summary of modules obtained from human only whole genome 837 
correlation network.  838 
  839 
Supplementary Fig 1. Estimates of the relative proportions of leukocyte subpopulations in subjects 840 
with severe and uncomplicated malaria. (A-E) Surrogate proportion variables, 841 
 are compared by severity category for neutrophils (A), monocytes (B), CD4+ T-842 
lymphocytes (C), CD8+ T-lymphocytes (D), and B-lymphocytes (E) using the Mann-Whitney test (UM, 843 
n=21; SM, n=25; bold line, box and whiskers indicate median, interquartile range and 1.5-times 844 
interquartile range respectively). 845 
  846 
Supplementary Fig 2. Validation of the gene-signature approach to estimate parasite 847 
developmental stage proportions. (A-C) Correlation of surrogate proportion variables (SPV), 848 
 with read counts for putative “stage-specific” marker genes (see 849 
Methods): (A) 0hr SPV vs. early asexual stage marker gene PFE0065w; (B) 48hr SPV vs. late asexual 850 
stage marker gene PF10_0020; (C) Gametocyte V SPV vs. developing gametocyte marker gene 851 
PF14_0367 (R for Pearson correlation, n=43). (D-G) Correlation of SPVs with actual proportion of 852 
reads derived from each parasite developmental stage in synthetic mixtures of varying proportions 853 
of stage-specific RNA-seq reads from early ring-stage (0 hour, D), trophozoite (24 hour, E), late 854 
schizont (48 hour, F) and mature gametocyte (Stage V, G). R for Pearson correlation, n=43.  855 
calculated using 
CellCODE,
calculated using CellCODE,
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  856 
Supplementary Fig 3. Differential gene expression between severe malaria phenotypes and 857 
uncomplicated malaria. Volcano plots showing extent and significance of up- or down- regulation of 858 
human (left hand column) or P. falciparum (right hand column) gene expression in comparisons 859 
between specific phenotypes of SM vs UM (red and green, P <0.05 after Benjamini-Hochberg 860 
adjustment for false discovery rate (FDR); orange and green, absolute log2-fold change (FC) in 861 
expression > 1).  862 
  863 
Supplementary Fig 4. Top functional network for the small LYSMD3 module. Functional networks 864 
were identified in Ingenuity Pathway Analysis software and the top scoring network is portrayed in 865 
radial layout which places the most interconnected gene at the centre. Genes within the module are 866 
shaded. 867 
 868 
. . (A-869 
DEFA3 870 
(A) and  (B) (n=34; SM, n=14; UM, n= 20). (C-E) Correlation between plasma MMP8 and MMP8 871 
872 
(with eigengene values for the MMP8 module derived from the 873 
 (analysis restricted to subjects with 874 
). (A-F) P and rho for Spearman correlation. (G) 875 
(n=8) before and after stimulation with P. 876 
3D7 schizont lysate, P for Wilcoxon matched pairs test. 877 
 878 
Supplementary Dataset 1. Subject-level clinical and laboratory data  879 
Supplementary Fig 5
B) Correlation between plasma protein concentrations and corresponding gene expression of 
ELANE
expression in all subjects (C, n=35) and separately in those with SM (D, n=15) or UM (E, n=20). (F) 
Correlation of plasma GCSF 
combined network analysis of subjects with SM and UM
detectable plasma GCSF, n=19; SM, n=8; UM, n=11
MMP8 release from healthy human adult donor blood 
falciparum 
Association between gene expression and plasma protein concentrations
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Table 1. Characteristics of study subjects (n=46) 902 
 
CM (n=5) CH (n=12) HL (n=8) UM (n=21) 
P (F 
value) 
Age (years) 4.3 (4.2-4.8) 4.9 (3.6-5.7) 5.0 (3.8-8.3) 6.0 (4.0-9.0) 0.24 
(1.47) 
Male (%) 3 (60%) 5 (42%) 7 (88%) 13 (62%) 0.24 
Parasitemia 
(%) 
8.3 (5.3-9.0)4 12.6 (9.4-19.0) 9.6 (1.8-12.2) 5.1 (3.8-7.0) 0.02 
(3.67) 
Parasites  
(x105 /uL) 
2.3 (1.7-3.1) 3 3.5 (2.7-8.4) 11 2.8 (0.7-5.0) 2.3 (1.6-3.2) 0.02 
(3.55) 
Clones 2 (1.5-2.5) 4 2 (1-2) 9 1 (1-2) 5 2 (1-2) 15 0.68 
(0.51) 
PfHRP2 
(ng/mL) 
202 (93-528) 4 763 (374-1750) 470 (164-2214) 163 (128-227) 0.001 
(6.20) 
Duration of 
illness (days) 
2.0 (1.7-3.0) 2.0 (2.0-2.5) 2.0 (2.0-3.5) 2.7 (2.0-3.0) 0.57 
(0.68) 
Hb (g/dL) 9.7 (7.4-10.4) 9.3 (7.8-11.5) 11 9.1 (7.4-11.0) 10.8 (9.9-12.1) 0.10 
(2.24) 
WBC (x109/L) 9.8 (8.2-12.9) 4 8.8 (6.4-9.4) 11 15.3 (7.9-16.8) 
7 
9.5 (7.7-11.8) 0.30 
(1.27) 
Platelets 
(x109/L) 
41 (40-82) 4 36 (23-65) 11 59 (33-132) 122 (96-132) 0.04 
(3.15) 
9/L) 
4 11 7 20 
Lymphocyte 
(%) 
29.8 
(20.6-37.3) 4 
37.8 
(29.9-49.9)11 
22.3 
(14.7-37.3)7 
23.9 
(16.0-33.5)20 
0.05 
(2.78) 
(x109  
4 10 7 20 
Neutrophil  
(%) 
55.1 
(49.0-69.6) 4 
48.3 
(39.6-56.2) 10 
61.5 
(55.6-74.9) 7 
68.0 
(59.9-79.6)20 
0.01 
(4.25) 
(x109  
4 10 7 20 
Monocyte  
(%) 
7.1 
(6.0-7.7)4 
7.8 
(6.8-8.6)10 
6.6 
(5.1-7.8) 7 
6.7 
(4.8-7.3)20 
0.38 
(1.05) 
CM, cerebral malaria; CH, cerebral malaria plus hyperlactatemia; HL, hyperlactatemia (CM, CH, and 903 
HL are all subgroups of severe malaria, SM); UM, uncomplicated malaria; PfHRP2, P. falciparum 904 
histidine rich protein 2; Hb, hemoglobin concentration; WBC, white blood cell count. Data are 905 
median (IQR), superscripts indicate the number of subjects with data for each variable if less than 906 
0.6 (0.6-0.7)Monocytes 
/L)
0.6 (0.5-0.9) 0.8 (0.6-1.3) 0.7 (0.4-0.9)
(0.75) 
0.53 
(1.79) 
0.17 7.0 (5.3-7.7)6.5 (5.8-10.4)4.0 (2.9-4.3)6.4 (4.0-8.7)Neutrophils 
/L)
(x10
Lymphocytes 2.7 (2.1-3.6) 2.9 (2.4-3.6) 3.1 (1.8-5.2) 2.4 (1.4-3.1)
(0.75) 
0.53 
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the total; P (F) for ANOVA comparing all groups (degrees of freedom =3) except for sex where P is for 907 
908 
909 
  910 
analyser. 
Fisher’s exact test. Leukocyte population numbers and proportions measured by clinical hematology 
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Table 2. Numbers of differentially expressed genes before and after adjustment for parasite load 911 
 912 
 Human genes Parasite genes 
 
n* Unadjusted 
Log 
parasite  
density 
Log 
PfHRP2 n* Unadjusted 
Log 
parasite  
density 
Log 
PfHRP2 
SM vs UM 43 907 914 
(101%) 
13 
(1.4%) 
41 516 562 
(109%) 
329 
(64%) 
BCS 43 738 491 
(67%) 
12 
(1.6%) 
41 445 
 
340 
(76%) 
148 
(33%) 
Lactate 40 1012 526 
(52%) 
51 
(5.0%) 
38 100 109 
(109%) 
47 
(47%) 
Platelets 43 178 66 
(37%) 
46 
(25%) 
41 1 1 
(100%) 
1 
(100%) 
Hemoglobin 43 0 0 0 41 6 5 
(83%) 
4 
(67%) 
*Only subjects with complete data for every parameter are included. Number of genes associated 913 
with severity category or laboratory marker of severity before and after adjustment for parasite load 914 
(% of number in unadjusted analysis where applicable). BCS, Blantyre coma scale. 915 
  916 
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Table 3. Parasite genes correlated with human gene co-expression modules after adjustment for 917 
parasite load 918 
Human Module Correlated parasite genes after adjustment for parasite load 
Hub gene Top GO 
term 
n 
(+/-) 
Top genes FDR P Top GO terms P 
Receptor 
Transporter 
Protein 4 
(RTP4) 
GO:0034340
response to 
type I 
interferon 
2 
(2/0) 
 
PF3D7_0827500 (apicoplast 
ribosomal protein L21 
precursor) 
0.014 
 
GO:0006412 
translation 
0.018 
PF3D7_0111800 (eukaryotic 
translation initiation factor 
4E) 
0.035 
Trinucleotide 
Repeat 
Containing 6B 
(TNRC6B) 
GO:0016569
chromatin 
modification 
97 
(29/ 
68) 
PF3D7_1119200 (unknown 
function) 
0.000
12 
GO:0008380 
RNA splicing 
4.15 
x10-6 
PF3D7_1309100 (60S 
ribosomal protein L24) 
0.000
27 
GO:0006396 
RNA 
processing 
3.88 
x10-5 
PF3D7_0825500 (protein 
KRI1) 
0.000
36 
  
Heat shock 
protein family 
H (Hsp110) 
member 1 
(HSPH1) 
 
GO:0006457
protein 
folding 
21 
(17/ 
4) 
PF3D7_0933100 (unknown 
function) 
0.007
1 
GO:0000338 
protein 
deneddylation 
0.0038 
PF3D7_1118400 (haloacid 
dehalogenase-like hydrolase) 
0.007
9 
PF3D7_0521800 (AFG1-like 
ATPase) 
0.01 
Matrix 
metallopeptid
-ase 8 (MMP8) 
GO:0009617
response to 
bacterium 
18 
(16/ 
2) 
PF3D7_1356200 
(mitochondrial import inner 
membrane translocase 
subunit TIM23) 
0.004
5 
GO:0019219 
regulation of 
nucleobase-
containing 
0.0065 
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PF3D7_1119100 (tRNA m(1)G 
methyltransferase) 
0.007
1 
compound 
metabolic 
process PF3D7_0823100 (RWD 
domain-containing protein) 
0.007
3 
Peptidylprolyl 
isomerase B 
(PPIB) 
GO:0034976
response to 
endoplasmic 
reticulum 
stress 
24  
(24/ 
0) 
PF3D7_1420300 (DNL-type 
zinc finger protein) 
0.002
2 
GO:0006364 
rRNA 
processing 
0.0058 
PF3D7_0821200 (unknown 
function) 
0.005
7 
PF3D7_1119200 (unknown 
function) 
0.005
7 
Ribosomal 
protein L24 
(RPL24) 
GO:0006614
SRP-
dependent 
co-
translational 
protein 
targeting to 
membrane 
93 
(78/ 
15) 
PF3D7_0530600 (XAP-5 DNA 
binding protein) 
5.3 
x10-6 
GO:0006396 
RNA 
processing 
6.92 
x10-4 
PF3D7_1309100 (60S 
ribosomal protein L24) 
5.3 
x10-6 
GO:0008380 
RNA splicing 
1.10 
x10-3 
PF3D7_0821200 (unknown 
function) 
3.3 
x10-5 
  
+/- indicates number of parasite genes positively / negatively correlated with each human module 919 
eigengene value. All “top genes” in the table are positively correlated with the module eigengene 920 
value.  921 
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